Johnson & Johnson and 32 Other Transvaginal Mesh Manufacturers Ordered by FDA to Study Complication Rates
The Food and Drug Administration wants 33 manufacturers of transvaginal mesh products to study the rates of health complications, including organ damage, linked to these medical devices. The mandate comes six months after the federal agency reported a fivefold increase in injuries, deaths, and malfunctions related to vaginal mesh implants. The FDA has said that it so far has been unable to verify whether transvaginal mesh provides greater benefits than more traditional devices used to treat stress urinary incontinence and pelvic organ prolapse. In fact, the federal agency has warned that mesh implants have been linked to pain during sex, bleeding, infection, severe pain, pelvic perforation, urinary tract erosion, perineal cellulitis, and organ perforation. If you or someone you love suffered health complications from transvaginal mesh, do not hesitate to contact our Charlotte, North Carolina defective medical device lawyers today.
CR Bard Inc., Endo Pharmaceuticals Holding Inc., and Johnson & Johnson, Boston Scientific are just a handful of the companies that the FDA has contacted. The federal regulator wants each manufacturer to gather data about potential complications and the outcomes of various transvaginal procedures and conduct trials on effectiveness and safety for three years. The FDA’s letters, which were sent out earlier this week, are calling for the studies to look into devices that are already available for use. Consumers, however, want mesh products that haven’t entered the market to be studied before they are released.
Currently, under the FDA’s 510(k) system, new mesh products that are similar to devices the federal agency has already approved don’t have to undergo human testing to receive their approval. Many of the transvaginal mesh implants that are currently in use can trace their approvals back to the Boston Scientific Corp. mesh (that was recalled in 1999.)
Transvaginal mesh devices have been blamed in over 650 products liability lawsuits against manufacturers. In 2010 alone, nearly 300,000 synthetic mesh products were implanted in women in the US.
Between 2008 and 2010 alone, the FDA was notified of 1,503 adverse occurrences related to mesh used in POP procedures—that’s 5 times more than the number of reports it received during the previous two years. It doesn’t help that for many of the women who experience transvaginal mesh complications they continued to experience ongoing pain afterwards. Additional surgeries to remove the medical device may have been required. (In some cases, the mesh can get so tangled up in scar tissue that it has to stay in the body.)
Our Charlotte, North Carolina transvaginal mesh lawyers know how devastating it can be to sustain injuries or health issues because a medical device failed and/or because of complications that you should’ve been warned about before you underwent the procedure.
J & J, CR Bard Must Study Safety of Vaginal Mesh, FDA says, Bloomberg, January 5, 2011
FDA warns against surgical mesh to repair pelvic problems, Boston.com, July 13, 2011
FDA Public Health Notification: Serious Complications Associated with Transvaginal Placement of Surgical Mesh in Repair of Pelvic Organ Prolapse and Stress Urinary Incontinence, FDA, July 13, 2011
More Blog Posts:


